The effects of bifidobacterium breve on immune mediators and proteome of ht29 cells monolayers

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Sánchez, Borja ^a   González Rodríguez, Irene ^a   Arboleya, Silvia ^a   López, Patricia ^b   Suárez, Ana ^b   Ruas Madiedo, Patricia ^a   Margolles, Abelardo ^a   Gueimonde, Miguel ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; CYTOKERATIN 8; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROBIOTIC AGENT; PROTEOME; TUMOR NECROSIS FACTOR ALPHA; CXCL6 PROTEIN, HUMAN; IMMUNOLOGIC FACTOR;

ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; CONTROLLED STUDY; GENE EXPRESSION; HT 29 CELL LINE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; INTESTINE MUCOSA; MEDIATOR RELEASE; MONOLAYER CULTURE; NONHUMAN; UPREGULATION; BIFIDOBACTERIUM; EPITHELIUM CELL; GENETICS; HT-29 CELL LINE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; TUMOR CELL LINE;

BIFIDOBACTERIUM BREVE;

BIFIDOBACTERIUM; CELL LINE, TUMOR; CHEMOKINE CXCL6; COMPLEMENT C3A; EPITHELIAL CELLS; HT29 CELLS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INTESTINAL MUCOSA; KERATIN-8; PROBIOTICS; PROTEOME; RECEPTORS, CCR7;

EID: 84924546209     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/479140     Document Type: Article

References (62)

1. Food and Health Agricultural Organization of the United Nations and World Health Organization, "Guidelines for the evaluation of probiotics in food," Working Group Report, FAO/WHO, Ontario, Canada, 2002.
2. T. Yatsunenko, F. E. Rey, M. J. Manary et al., "Human gut microbiome viewed across age and geography," Nature, Vol. 486, no. 7402, pp. 222-227, 2012.
3. M. C. Collado, M. Gueimonde, and G. Pérez-Martínez, "Current and future applications of probiotics," Current Nutrition and Food Science, Vol. 7, no. 3, pp. 170-180, 2011.
4. M. G. Gareau, P. M. Sherman, and W. A. Walker, "Probiotics and the gut microbiota in intestinal health and disease," Nature reviews. Gastroenterology & hepatology, Vol. 7, no. 9, pp. 503-514, 2010.
5. N. Binns, Probiotics, Prebiotics and the Gut Microbiota, ILSI Europe Concise Monograph Series, International Life Sciences Institute, 2013.
6. C. L. Maynard, C. O. Elson, R. D. Hatton, and C. T. Weaver, "Reciprocal interactions of the intestinal microbiota and immune system," Nature, Vol. 489, no. 7415, pp. 231-241, 2012.
7. H. R. Christensen, H. Frøkiær, and J. J. Pestka, "Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells," The Journal of Immunology, Vol. 168, no. 1, pp. 171-178, 2002.
8. P. López, M. Gueimonde, A. Margolles, and A. Suárez, "Distinct Bifidobacterium strains drive different immune responses in vitro," International Journal of Food Microbiology, Vol. 138, no. 1-2, pp. 157-165, 2010.
9. A. Swidsinski, V. Loening-Baucke, H. Lochs, and L. P. Hale, "Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice," World Journal of Gastroenterology, Vol. 11, no. 8, pp. 1131-1140, 2005.
10. P. Brandtzaeg, "The gut as communicator between environment and host: Immunological consequences," European Journal of Pharmacology, Vol. 668, supplement 1, pp. S16-S32, 2011.
11. S. Arboleya, P. Ruas-Madiedo, A. Margolles et al., "Characterization and in vitro properties of potentially probiotic Bifidobacterium strains isolated from breast-milk," International Journal of Food Microbiology, Vol. 149, no. 1, pp. 28-36, 2011.
12. P. López, I. González-Rodríguez, M. Gueimonde, A. Margolles, and A. Suárez, "Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity," PLoS ONE, Vol. 6, no. 9, Article ID e24776, 2011.
13. P. López, I. González-Rodríguez, B. Sánchez et al., "Interaction of Bifidobacterium bifidum LMG13195 with HT29 Cells Influences regulatory-T-cell-associated chemokine receptor expression," Applied and Environmental Microbiology, Vol. 78, no. 8, pp. 2850-2857, 2012.
14. D. R. Mack, S. Ahrne, L. Hyde, S. Wei, and M. A. Hollingsworth, "Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro," Gut, Vol. 52, no. 6, pp. 827-833, 2003.
15. M. Schlee, J. Harder, B. Köten, E. F. Stange, J. Wehkamp, and K. Fellermann, "Probiotic lactobacilli and VSL#3 induce entero-cyte β-defensin 2," Clinical and Experimental Immunology, Vol. 151, no. 3, pp. 528-535, 2008.
16. R. Paolillo, C. R. Carratelli, S. Sorrentino, N. Mazzola, and A. Rizzo, "Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells," International Immunopharmacology, Vol. 9, no. 11, pp. 1265-1271, 2009.
17. S. di Caro, H. Tao, A. Grillo et al., "Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa," Digestive and Liver Disease, Vol. 37, no. 5, pp. 320-329, 2005.
18. F. J. Troost, P. Van Baarlen, P. Lindsey et al., "Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo," BMC Genomics, Vol. 9, article 374, 2008.
19. P. Van Baarlen, F. Troost, C. van der Meer et al., "Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways," Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, no. 1, pp. 4562-4569, 2011.
20. C. U. Riedel, F. Foata, D. R. Goldstein, S. Blum, and B. J. Eikmanns, "Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles," International Journal of Food Microbiology, Vol. 110, no. 1, pp. 62-68, 2006.
21. T. Shima, K. Fukushima, H. Setoyama et al., "Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria," FEMS Immunology and Medical Microbiology, Vol. 52, no. 1, pp. 69-77, 2008.
22. J.-G. Lan, S. M. Cruickshank, J. C. I. Singh et al., "Different cytokine response of primary colonic epithelial cells to commensal bacteria," World Journal of Gastroenterology, Vol. 11, no. 22, pp. 3375-3384, 2005.
23. J. H. Niess and H. C. Reinecker, "Chemokines in immune surveillance of the intestine," Current Topics in Membranes, Vol. 55, pp. 143-158, 2005.
24. A. Cebula, M. Seweryn, G. A. Rempala et al., "Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota," Nature, Vol. 497, no. 7448, pp. 258-262, 2013.
25. A. Wuyts, S. Struyf, K. Gijsbers et al., "The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1β and is down-regulated by interferon-γ: comparison with interleukin-8/CXCL8," Laboratory Investigation, Vol. 83, no. 1, pp. 23-34, 2003.
26. T. Olszak, D. An, S. Zeissig et al., "Microbial exposure during early life has persistent effects on natural killer T cell function," Science, Vol. 336, no. 6080, pp. 489-493, 2012.
27. A. Sahu and J. D. Lambris, "Structure and biology of complement protein C3, a connecting link between innate and acquired immunity," Immunological Reviews, Vol. 180, pp. 35-48, 2001.
28. M. R. Stone, A. O'Neill, D. Catino, and R. J. Bloch, "Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19," Molecular Biology of the Cell, Vol. 16, no. 9, pp. 4280-4293, 2005.
29. P. A. Wearsch and P. Cresswell, "in vitro reconstitution of the MHC class I peptide-loading complex," Methods in Molecular Biology, Vol. 960, pp. 67-79, 2013.
30. P. A. Wearsch and P. Cresswell, "Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer," Nature Immunology, Vol. 8, no. 8, pp. 873-881, 2007.
31. R. Kaneno, G. V. Shurin, F. M. Kaneno, H. Naiditch, J. Luo, and M. R. Shurin, "Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells," Cellular Oncology, Vol. 34, no. 2, pp. 97-106, 2011.
32. Food and Health Agricultural Organization of the United Nations and World Health Organization, "Guidelines for the evaluation of probiotics in food," Working Group Report, FAO/WHO, Ontario, Canada, 2002.
33. T. Yatsunenko, F. E. Rey, M. J. Manary et al., "Human gut microbiome viewed across age and geography," Nature, Vol. 486, no. 7402, pp. 222-227, 2012.
34. M. C. Collado, M. Gueimonde, and G. Pérez-Martínez, "Current and future applications of probiotics," Current Nutrition and Food Science, Vol. 7, no. 3, pp. 170-180, 2011.
35. M. G. Gareau, P. M. Sherman, and W. A. Walker, "Probiotics and the gut microbiota in intestinal health and disease," Nature reviews. Gastroenterology & hepatology, Vol. 7, no. 9, pp. 503-514, 2010.
36. N. Binns, Probiotics, Prebiotics and the Gut Microbiota, ILSI Europe Concise Monograph Series, International Life Sciences Institute, 2013.
37. C. L. Maynard, C. O. Elson, R. D. Hatton, and C. T. Weaver, "Reciprocal interactions of the intestinal microbiota and immune system," Nature, Vol. 489, no. 7415, pp. 231-241, 2012.
38. H. R. Christensen, H. Frøkiær, and J. J. Pestka, "Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells," The Journal of Immunology, Vol. 168, no. 1, pp. 171-178, 2002.
39. P. López, M. Gueimonde, A. Margolles, and A. Suárez, "Distinct Bifidobacterium strains drive different immune responses in vitro," International Journal of Food Microbiology, Vol. 138, no. 1-2, pp. 157-165, 2010.
40. A. Swidsinski, V. Loening-Baucke, H. Lochs, and L. P. Hale, "Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice," World Journal of Gastroenterology, Vol. 11, no. 8, pp. 1131-1140, 2005.
41. P. Brandtzaeg, "The gut as communicator between environment and host: Immunological consequences," European Journal of Pharmacology, Vol. 668, supplement 1, pp. S16-S32, 2011.
42. S. Arboleya, P. Ruas-Madiedo, A. Margolles et al., "Characterization and in vitro properties of potentially probiotic Bifidobacterium strains isolated from breast-milk," International Journal of Food Microbiology, Vol. 149, no. 1, pp. 28-36, 2011.
43. P. López, I. González-Rodríguez, M. Gueimonde, A. Margolles, and A. Suárez, "Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity," PLoS ONE, Vol. 6, no. 9, Article ID e24776, 2011.
44. P. López, I. González-Rodríguez, B. Sánchez et al., "Interaction of Bifidobacterium bifidum LMG13195 with HT29 Cells Influences regulatory-T-cell-associated chemokine receptor expression," Applied and Environmental Microbiology, Vol. 78, no. 8, pp. 2850-2857, 2012.
45. D. R. Mack, S. Ahrne, L. Hyde, S. Wei, and M. A. Hollingsworth, "Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro," Gut, Vol. 52, no. 6, pp. 827-833, 2003.
46. M. Schlee, J. Harder, B. Köten, E. F. Stange, J. Wehkamp, and K. Fellermann, "Probiotic lactobacilli and VSL#3 induce entero-cyte β-defensin 2," Clinical and Experimental Immunology, Vol. 151, no. 3, pp. 528-535, 2008.
47. R. Paolillo, C. R. Carratelli, S. Sorrentino, N. Mazzola, and A. Rizzo, "Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells," International Immunopharmacology, Vol. 9, no. 11, pp. 1265-1271, 2009.
48. S. di Caro, H. Tao, A. Grillo et al., "Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa," Digestive and Liver Disease, Vol. 37, no. 5, pp. 320-329, 2005.
49. F. J. Troost, P. Van Baarlen, P. Lindsey et al., "Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo," BMC Genomics, Vol. 9, article 374, 2008.
50. P. Van Baarlen, F. Troost, C. van der Meer et al., "Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways," Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, no. 1, pp. 4562-4569, 2011.
51. C. U. Riedel, F. Foata, D. R. Goldstein, S. Blum, and B. J. Eikmanns, "Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles," International Journal of Food Microbiology, Vol. 110, no. 1, pp. 62-68, 2006.
52. T. Shima, K. Fukushima, H. Setoyama et al., "Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria," FEMS Immunology and Medical Microbiology, Vol. 52, no. 1, pp. 69-77, 2008.
53. J.-G. Lan, S. M. Cruickshank, J. C. I. Singh et al., "Different cytokine response of primary colonic epithelial cells to commensal bacteria," World Journal of Gastroenterology, Vol. 11, no. 22, pp. 3375-3384, 2005.
54. J. H. Niess and H. C. Reinecker, "Chemokines in immune surveillance of the intestine," Current Topics in Membranes, Vol. 55, pp. 143-158, 2005.
55. A. Cebula, M. Seweryn, G. A. Rempala et al., "Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota," Nature, Vol. 497, no. 7448, pp. 258-262, 2013.
56. A. Wuyts, S. Struyf, K. Gijsbers et al., "The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1β and is down-regulated by interferon-γ: comparison with interleukin-8/CXCL8," Laboratory Investigation, Vol. 83, no. 1, pp. 23-34, 2003.
57. T. Olszak, D. An, S. Zeissig et al., "Microbial exposure during early life has persistent effects on natural killer T cell function," Science, Vol. 336, no. 6080, pp. 489-493, 2012.
58. A. Sahu and J. D. Lambris, "Structure and biology of complement protein C3, a connecting link between innate and acquired immunity," Immunological Reviews, Vol. 180, pp. 35-48, 2001.
59. M. R. Stone, A. O'Neill, D. Catino, and R. J. Bloch, "Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19," Molecular Biology of the Cell, Vol. 16, no. 9, pp. 4280-4293, 2005.
60. P. A. Wearsch and P. Cresswell, "in vitro reconstitution of the MHC class I peptide-loading complex," Methods in Molecular Biology, Vol. 960, pp. 67-79, 2013.
61. P. A. Wearsch and P. Cresswell, "Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer," Nature Immunology, Vol. 8, no. 8, pp. 873-881, 2007.
62. R. Kaneno, G. V. Shurin, F. M. Kaneno, H. Naiditch, J. Luo, and M. R. Shurin, "Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells," Cellular Oncology, Vol. 34, no. 2, pp. 97-106, 2011.